Novavax cut $50 million in costs, plans to slash more, CEO says
By Patrick Wingrove (Reuters) - Novavax Inc cut about $50 million in costs in the first quarter of 2023 and plans to slash more, Chief Executive John ...
Source: whbl.com
Page 39 - Patrick Wingrove News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Patrick Wingrove. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Patrick Wingrove Today - Breaking & Trending Today
Moderna says flu shot misses early success bar, but expects 2024 revenue
Moderna Inc said on Tuesday its experimental flu vaccine did not meet the criteria for early success in a late-stage trial, and its shares fell 3%. The U.S. biotech company at its... | June 19, 2023
Source: marketscreener.com
Moderna flu shot misses 'early success' bar, shares fall
Moderna Inc said on Tuesday its experimental flu vaccine did not meet the criteria for early success in a late-stage trial, and its shares fell 3%. The U.S. biotech company at its... | June 19, 2023
Source: marketscreener.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ICEGN3FQKFNIFACSOMHCVLKS6Q.jpg)
Moderna says flu shot misses early success bar, but expects 2024 revenue
Moderna Inc said on Tuesday its experimental flu vaccine did not meet the criteria for "early success" in a late-stage trial, and its shares fell 3%.
Source: reuters.com
/cloudfront-us-east-2.images.arcpublishing.com/reuters/NWVYCKZSCJKIFPAM6YAO2VYM74.jpg)
FDA's Marks hopes to align global regulators to boost gene therapy
U.S. Food and Drug Administration official Peter Marks said on Wednesday he hopes to align global regulations to boost commercialization for gene and cell therapies to get more treatments launched for patients with rare diseases.
Source: reuters.com